✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Beryl Drugs Ltd.

BERLDRG

Market Cap
₹12 Cr.
P/E
28.04

Beryl Drugs Ltd.

  • Beryl Drugs
  • Link Pharma Chem
  • Emmessar Biotech&Nut

FAQs on Beryl Drugs Ltd. Shareprice

Beryl Drugs has given lower returns compared to its competitors.
Beryl Drugs has grown at ~-18.18% over the last 2yrs while peers have grown at a median rate of -9.17%

Beryl Drugs is not expensive.
Latest PE of Beryl Drugs is 28.04, while 3 year average PE is 75.53.
Also latest EV/EBITDA of Beryl Drugs is 5.82 while 3yr average is 8.73.

View FAQ's On Business

Growth Table

  • Beryl Drugs Ltd.
  • Link Pharma Chem
  • Emmessar Biotech&Nut

Balance Sheet

  • Beryl Drugs Ltd.
  • Link Pharma Chem
  • Emmessar Biotech&Nut

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Beryl Drugs Ltd.
  • Link Pharma Chem
  • Emmessar Biotech&Nut

Cash Flow

  • Beryl Drugs Ltd.
  • Link Pharma Chem
  • Emmessar Biotech&Nut

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Beryl Drugs Ltd.
  • Link Pharma Chem
  • Emmessar Biotech&Nut

Quarterly Results

  • Beryl Drugs Ltd.
  • Link Pharma Chem
  • Emmessar Biotech&Nut

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Beryl Drugs Ltd. Financials

Balance sheet of Beryl Drugs is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Beryl Drugs is decreasing.
Latest net debt of Beryl Drugs is ₹2.12 Crs as of Mar-26.
This is less than Mar-25 when it was ₹2.5 Crs.

The profit is oscillating.
The profit of Beryl Drugs is ₹0.58 Crs for Mar 2025, ₹0.77 Crs for Mar 2024 and ₹0.77 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Beryl Drugs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech